NEW YORK--(BUSINESS WIRE)--Standard & Poor’s announced today that it has commenced Factual Stock Report coverage on Vicor Technologies, Inc. Vicor Technologies is a biotechnology company focused on the commercialization of innovative, non-invasive medical devices and diagnostics using its patented, proprietary PD2i® nonlinear algorithm and software to identify trauma patients in need of a lifesaving intervention, patients at risk of sudden cardiac death, and patients with autonomi
For more information, please visit
http://www.businesswire.com/news/home/20091222005150/en